Carcinoma, Bronchogenic  >>  Perjeta (pertuzumab)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Perjeta (pertuzumab) / Roche
NCT02507375: A Study of Pertuzumab With Erlotinib in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Completed
1
17
Europe
Erlotinib, Tarceva, Pertuzumab, Perjeta
Hoffmann-La Roche
Non-Small Cell Lung Cancer
12/08
12/08

Download Options